It’s been a year since Mieczysław Starkowicz has become the president of the company's management board. What were the most important events during this time?
‘The most important event was the completion of the construction of the Research and Development Center. CBR is our greatest pride, the object of our efforts and care. This complex project will change the company, because thanks to the investment it will be possible to improve the technology for innovative products, and thus increase Synthaverse’s competitiveness on an international scale,’ emphasizes Mieczysław Starkowicz, president of the management board of Synthaverse S.A.
‘During this year, we introduced significant changes in the organization itself. We rebuilt it and added new values, which is extremely valuable in business when you open a company to the world. Building a commercial team is also an important step, notes the president of Synthaverse,’ he adds.
What are your plans for the second year?
‘We want to sign many license agreements for our products, not only in Western Europe, but also outside of it. We have an appetite for the world's largest pharmaceutical markets. The team's work focuses on these contracts. From 2026, we want to use the full power of the new line of the Onko BCG Production Plant, the construction of which is nearing completion,’ sums up Mieczysław Starkowicz.
August 2023
